Infectious Diseases Area, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, USA.
J Bacteriol. 2012 Oct;194(19):5171-84. doi: 10.1128/JB.00792-12. Epub 2012 Jun 29.
The prototypical type II fatty acid synthesis (FAS) pathway in bacteria utilizes two distinct classes of β-ketoacyl synthase (KAS) domains to assemble long-chain fatty acids, the KASIII domain for initiation and the KASI/II domain for elongation. The central role of FAS in bacterial viability and virulence has stimulated significant effort toward developing KAS inhibitors, particularly against the KASIII domain of the β-acetoacetyl-acyl carrier protein (ACP) synthase FabH. Herein, we show that the opportunistic pathogen Pseudomonas aeruginosa does not utilize a FabH ortholog but rather a new class of divergent KAS I/II enzymes to initiate the FAS pathway. When a P. aeruginosa cosmid library was used to rescue growth in a fabH downregulated strain of Escherichia coli, a single unannotated open reading frame, PA5174, complemented fabH depletion. While deletion of all four KASIII domain-encoding genes in the same P. aeruginosa strain resulted in a wild-type growth phenotype, deletion of PA5174 alone specifically attenuated growth due to a defect in de novo FAS. Siderophore secretion and quorum-sensing signaling, particularly in the rhl and Pseudomonas quinolone signal (PQS) systems, was significantly muted in the absence of PA5174. The defect could be repaired by intergeneric complementation with E. coli fabH. Characterization of recombinant PA5174 confirmed a preference for short-chain acyl coenzyme A (acyl-CoA) substrates, supporting the identification of PA5174 as the predominant enzyme catalyzing the condensation of acetyl coenzyme A with malonyl-ACP in P. aeruginosa. The identification of the functional role for PA5174 in FAS defines the new FabY class of β-ketoacyl synthase KASI/II domain condensation enzymes.
原核生物中典型的 II 型脂肪酸合成(FAS)途径利用两类不同的β-酮酰基合酶(KAS)结构域来组装长链脂肪酸,KASIII 结构域用于起始,KASI/II 结构域用于延伸。FAS 在细菌的生存力和毒力中的核心作用促使人们大力开发 KAS 抑制剂,特别是针对β-乙酰乙酰酰基辅酶 A(ACP)合酶 FabH 的 KASIII 结构域。本文表明,机会性病原体铜绿假单胞菌不使用 FabH 同源物,而是利用一类新的、分化的 KASI/II 酶来启动 FAS 途径。当使用铜绿假单胞菌的 cosmid 文库来挽救下调 fabH 的大肠杆菌菌株的生长时,一个未注释的单一开放阅读框 PA5174 能够弥补 fabH 的缺失。虽然在同一铜绿假单胞菌菌株中删除所有四个 KASIII 结构域编码基因导致野生型生长表型,但单独删除 PA5174 会导致由于从头 FAS 缺陷而导致生长受阻。铁载体分泌和群体感应信号,特别是在 rhl 和 Pseudomonas quinolone signal (PQS) 系统中,在没有 PA5174 的情况下显著减弱。通过与大肠杆菌 fabH 的种间互补,可以修复缺陷。重组 PA5174 的特性证实了其对短链酰基辅酶 A(酰基-CoA)底物的偏好,支持了 PA5174 作为铜绿假单胞菌中乙酰辅酶 A 与丙二酰-ACP 缩合的主要酶的鉴定。PA5174 在 FAS 中的功能作用的鉴定定义了 FabY 类新的β-酮酰基合酶 KASI/II 结构域缩合酶。